(Q44494028)

English

Impact of valganciclovir prophylaxis on the development of severe late-cytomegalovirus disease in high-risk solid organ transplant recipients

scientific article published in September 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Impact of valganciclovir prophylaxis on the development of severe late-cytomegalovirus disease in high-risk solid organ transplant recipients (English)

1 reference

Europe PubMed Central

3 December 2017

Cytomegalovirus

0 references

1 reference

based on heuristic

inferred from title

Maria Angeles Marcos

4

1 reference

Europe PubMed Central

3 December 2017

Tomàs Pumarola Suñé

11

1 reference

Europe PubMed Central

3 December 2017

object named as

C Cervera

1

0 references

author name string

M Pineda

2

1 reference

Europe PubMed Central

3 December 2017

L Linares

3

1 reference

Europe PubMed Central

3 December 2017

C Esteva

5

1 reference

Europe PubMed Central

3 December 2017

A Antón

6

1 reference

Europe PubMed Central

3 December 2017

F Cofán

7

1 reference

Europe PubMed Central

3 December 2017

M J Ricart

8

1 reference

Europe PubMed Central

3 December 2017

M Navasa

9

1 reference

Europe PubMed Central

3 December 2017

F Pérez-Villa

10

1 reference

Europe PubMed Central

3 December 2017

A Moreno

12

1 reference

Europe PubMed Central

3 December 2017

language of work or name

0 references

publication date

1 September 2007

1 reference

Europe PubMed Central

3 December 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

3 December 2017

39

1 reference

Europe PubMed Central

3 December 2017

2228-2230

1 reference

Europe PubMed Central

3 December 2017

7

1 reference

Europe PubMed Central

3 December 2017

Antibody maturation and viremia after primary cytomegalovirus infection, in immunocompetent patients and kidney-transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.07.039

7 January 2021

Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.07.039

7 January 2021

Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.07.039

7 January 2021

Consensus document from GESITRA-SEIMC on the prevention and treatment of cytomegalovirus infection in transplanted patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.07.039

7 January 2021

Definitions of cytomegalovirus infection and disease in transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.07.039

7 January 2021

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.07.039

7 January 2021

Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.07.039

7 January 2021

Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.07.039

7 January 2021

Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.07.039

7 January 2021

Antiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.07.039

7 January 2021

The case for cytomegalovirus prophylaxis in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.07.039

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2007.07.039

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44494028&oldid=2025706545"